- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02233608
Advanced Pelvic Floor Training Program for Prostate Cancer Surgery (AFPX)
October 24, 2017 updated by: Daniel Santa Mina, University of Guelph-Humber
A Randomized Pilot Study of Conventional Versus Advanced Pelvic Floor Exercises to Treat Urinary Incontinence After Radical Prostatectomy
Radical prostatectomy is a common and effective treatment for prostate cancer but is associated with urinary incontinence that can persist for several months after surgery and significantly reduce quality of life.
Studies have shown that routine performance of pelvic floor exercises after radical prostatectomy can aid in the recovery of urinary control; however, conventional pelvic floor exercises do not produce consistent results.
Research indicates that incorporating other deep abdominal muscles can further activate the pelvic floor making it stronger than by activating the pelvic floor alone.
Specifically, 'Pfilates' and 'Hypopressives' are two new techniques that combine traditional pelvic floor exercises with activation of supportive muscles.
Our proposed study will be the first to test the effect of an advanced pelvic floor exercise training program that includes Pfilates and Hypopressives to treat urinary incontinence following radical prostatectomy.
Our primary aim of this study is to assess the feasibility of conducting a full-scale RCT of an advanced pelvic floor exercise training program, including standard pelvic floor exercises, Pfilates, and Hypopressives techniques on urinary incontinence.
Feasibility will be determined by measuring recruitment success, retention, outcome capture, and intervention adherence, tolerance, and safety.
We hypothesize men under going radical prostatectomy for prostate cancer in the advance pelvic floor training program will report greater improvement in urinary incontinence and health-related quality of life.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
88
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 2C4
- University Health Network
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Men with localized prostate cancer (stage cT1-cT2) who have consented for radical prostatectomy (open retropubic, laparoscopic, robot-assisted laparoscopic)
- Between the the ages of 40 and 80 years
- Proficient in English
Exclusion Criteria:
- i) Diagnosed with a known neurological disease, autoimmune connective tissue disorder;
- ii) Have prior experience with pelvic floor training by a healthcare provider;
- iii) Have uncontrolled hypertension;
- iv) Have diagnosed COPD (Chronic Obstructive Pulmonary Disease) and/or chronic restrictive respiratory disease; or
- v) Have a history of inguinal herniation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care
The usual care group will receive generic pelvic floor muscle exercise (PMFX) instructions and demonstrations by the research coordinator at the initial post-operative time point.
This will include instruction on how to engage the pelvic floor and specific PFMX prescription.
Repetition volume will start at 20 repetitions per day during weeks 1-2; 60/day during weeks 3-4; and 90/day during weeks 5-6, and 100+/day for weeks 7-26.
The total number of repetitions will be divided equally between rhythmic (contract and relaxed over one second) and sustained contractions (contract and hold for up to 10 seconds).
|
|
Experimental: Advanced Pelvic Floor Exercise (APFX)
Participants in this group will receive detailed week-by-week description of the program.
The program progresses participants through stages of training every two weeks, starting the introduction of basic PFMX, and slowly incorporates Pfilates and Hypopressives exercises until week 8, where patients will maintain the final stage of training until week 26 or urinary incontinence is completely resolved.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment
Time Frame: When recruitment is complete (approximately 12 months after study initiation; October 2015)
|
Prior pelvic floor training trials in prostate cancer patients undergoing radical prostatectomy have observed recruitment rates of 21-70%.
We will measure recruitment success through participant recruitment per week and record reasons for non-participation from those who inquire about the study and are eligible to participate but refuse.
|
When recruitment is complete (approximately 12 months after study initiation; October 2015)
|
Adherence to intervention group
Time Frame: 26 weeks post-operatively
|
Adherence to the two groups (standard pelvic floor exercises and advanced pelvic floor exercises) will be measured through a logbook that is included in their respective program manuals as well as a logbook completed by the research coordinator during the weekly telephone communications.
|
26 weeks post-operatively
|
Study retention
Time Frame: 26 weeks post-operative
|
Retention will be assessed by measuring attrition throughout the intervention period and at each assessment.
|
26 weeks post-operative
|
24-hour Pad Test for Urinary Leakage
Time Frame: At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operatively
|
A 24-hour pad test will be used to measure urinary incontinence by assessing the quantity of urine lost in one day.
A urinary leakage pad is measured after a 24-hour period and compared to the unused pad weight and is used to most accurately assess the severity of urinary incontinence.
|
At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operatively
|
Pelvic Floor Strength
Time Frame: At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26, weeks post-operatively
|
Digital rectal examination of pelvic floor strength by a specially trained pelvic floor physiotherapist will be conducted.
Pelvic floor strength will be graded on the Modified Oxford Scale.
|
At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26, weeks post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Life
Time Frame: At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operative
|
Prostate specific quality of life will be measured using the Functional Assessment of Cancer Treatment-Prostate (FACT-P) and the Patient-Oriented Prostate Utility Scale (PORPUS).
|
At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operative
|
3-Day Bladder Diary for Urinary Incontinence
Time Frame: At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively
|
The bladder diary is a standard instrument for self-reporting voiding patterns.
Items include fluid intake, frequency of toilet voids, episode of urine loss, number of pads used, and activity during event for the three-day period.
Bladder diaries are widely used in clinical trials assessing urinary incontinence after radical prostatectomy.
|
At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively
|
Self-Reported Urinary Incontinence, Prostate Symptoms, and Erectile Function
Time Frame: At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively
|
Urological symptoms are assessed using the International Prostate Symptom Score (IPSS).
Additional, a single item regarding leaking urine and bladder control from the PORPUS will be used to evaluate incontinence.
Erectile function will be assessed using the 5-item International Index of Erectile Function scale (5-IIEF).
|
At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively
|
Body Composition
Time Frame: At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively
|
Body composition will be assessed via bioelectrical impedance analysis, height, weight, waist and hip circumference, and body mass index.
|
At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively
|
Physical Activity
Time Frame: At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operatively
|
Physical activity level will be measured wight he 3-item Godin Leisure Time Exercise Questionnaire - Leisure Score Index (GLTEQ-LSI).
|
At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
September 28, 2017
Study Completion (Actual)
September 28, 2017
Study Registration Dates
First Submitted
September 3, 2014
First Submitted That Met QC Criteria
September 3, 2014
First Posted (Estimate)
September 8, 2014
Study Record Updates
Last Update Posted (Actual)
October 26, 2017
Last Update Submitted That Met QC Criteria
October 24, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D2014-20
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer Patients Undergoing Radical Prostatectomy
-
University of Guelph-HumberUniversity Health Network, Toronto; McGill University Health Centre/Research... and other collaboratorsCompletedProstate Cancer Patients Undergoing Radical ProstatectomyCanada
-
Sohag UniversityCompletedPatients Undergoing Modified Radical MastectomyEgypt
-
University of California, San FranciscoCompletedMen With Prostate Cancer Undergoing Robot Assisted Radical ProstatectomyUnited States
-
Yonsei UniversityCompletedRobot-assisted Laparoscopic Radical Prostatectomy Undergoing General AnesthesiaKorea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingPatients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyChina
-
NycomedCompletedControl of Local Bleeding in Patients Undergoing Prostatectomy.Denmark
-
Biozeus Biopharmaceutical S.A.Azidus Brasil Scientific Research and Development LtdaCompletedErectile Dysfunction | Prostate Cancer | Radical Prostatectomy | Erectile Dysfunction Following Radical ProstatectomyBrazil
-
Yonsei UniversityRecruitingPatients Undergoing Transurethral Prostate or Cystectomy Under Spinal AnesthesiaKorea, Republic of
-
Wuerzburg University HospitalUniversitaire Ziekenhuizen KU LeuvenTerminatedProstate Cancer | Radical ProstatectomyGermany
-
Sunnybrook Health Sciences CentreRecruitingRadical Prostatectomy | SBRTCanada
Clinical Trials on Advanced Pelvic Floor Muscle Exercise (APFX)
-
Taipei Medical University WanFang HospitalUnknown
-
YI-JU TSAIWithdrawn
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)Completed
-
Trakya UniversityEnrolling by invitationMenopause | Stress Urinary Incontinence | Kegel Exercises | Core StrengthTurkey
-
National Cheng Kung UniversityCompletedUrinary Incontinence | Pelvic Floor Muscle WeaknessTaiwan
-
Universidade Federal do Rio Grande do NorteCompletedPhysical Activity | Sexual Dysfunctions, Psychological | Sexual Dysfunction, PhysiologicalBrazil
-
University of AlbertaPhysiotherapy Alberta - College + AssociationCompleted
-
The Hong Kong Polytechnic UniversityRecruitingStress Urinary IncontinenceHong Kong